Regeneron Pharmaceuticals Inc (REGN)

Exchange
NASDAQ
Symbol
REGN
Sector
Life Sciences
Industry
Pharmaceutical Preparations
Description
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its name, the company then branched out into the study of both cytokine and tyrosine kinase receptors.
Country
USA

Stock price

At close: November 6, 2024

  • Open
    844.51
  • High
    844.51
  • Low
    813.53
  • Close
    816.65
  • Volume
    874,502

Financial ratios

Dec 31, 2023

Activity ratios
Inventory turnover
1.10
Receivables turnover
2.30
Payables turnover
4.68
Working capital turnover
0.81
Days of inventory on hand (DOH)
331.61
Days of sales outstanding (DSO)
158.58
Number of days of payables
77.95
Fixed asset turnover
3.68
Total asset turnover
0.39
 Liquidity ratios
Current ratio
5.69
Quick ratio
4.82
Cash ratio
3.17
Cash conversion cycle
412.24
 Solvency ratios
Debt-to-assets ratio
0.06
Debt-to-capital ratio
0.07
Debt-to-equity ratio
0.08
Financial leverage ratio
1.27
Interest coverage
58.52
 Profitability ratios
Gross profit margin
78.23%
Operating profit margin
31.03%
Pretax margin
32.19%
Net profit margin
30.31%
Operating return on assets (Operating ROA)
12.23%
Return on assets (ROA)
11.95%
Return on total capital
15.28%
Return on equity (ROE)
15.22%